Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil

Cardiovascular Drugs and Therapy

Volumn 16, Issue 3, 2002, Pages 183-193

  Nebe, Barbara ^a   Holzhausen, Christian ^a   Rychly, Joachim ^a   Urbaszek, Wilhelm ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Adhesion; Calcium antagonist; Cytoskeleton; Integrin; Leukocytes

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; AMLODIPINE; BETA2 INTEGRIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; L SELECTIN; MIBEFRADIL; VERAPAMIL; CD18 ANTIGEN;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CALCIUM TRANSPORT; CHRONIC INFLAMMATION; CONTROLLED STUDY; CROSS LINKING; CYTOSKELETON; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ADULT; CELL ADHESION; CELL CULTURE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; LEUKOCYTE; MALE; METABOLISM; PHYSIOLOGY;

ADULT; AMLODIPINE; ANTIGENS, CD18; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; CELL ADHESION; CELLS, CULTURED; CYTOSKELETON; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; L-SELECTIN; LEUKOCYTES; MALE; MIBEFRADIL; MICROSCOPY, CONFOCAL; VERAPAMIL;

EID: 0036437739     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020688019792     Document Type: Article

References (57)

1. Girard JP, Springer TA. High endothelial venules (HEVs): Specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-457.
2. Harlan JM. Leukocyte-endothelial interactions. Blood 1985;65:513-525.
3. Imhof BA, Dunon D. Leukocyte migration and adhesion. Adv Immunol 1995;58:345-416.
4. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. Faseb J 1994;8:504-512.
5. Lefer AM, Weyrich AS, Buerke M. Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res 1994;28:289-294.
6. Schachter M. Calcium antagonists and atherosclerosis. Int J Cardiol 1997;62 (Suppl 2):S9-S15.
7. Dunon D, Piali L, Imhof BA. To stick or not to stick: The new leukocyte homing paradigm. Curr Opin Cell Biol 1996;8:714-723.
8. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101.
9. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, Dustin ML. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med 1995;182:1231-1241.
10. Meerschaert J, Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol 1995;154:4099-4112.
11. Clark EA, Brugge JS. Integrins arid signal transduction pathways: The road taken. Science 1995;268:233-239.
12. 2+ signaling in Jurkat T lymphocytes. J Immunol 1997;158:1618-1627.
13. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol 1994;4:506-517.
14. Williams MA, Solomkin JS. Integrin-mediated signaling in human neutrophil functioning. J Leukoc Biol 1999;65:725-736.
15. Lowell CA, Berton G. Integrin signal transduction in myeloid leukocytes. J Leukoc Biol 1999;65:313-320.
16. Peter K, O'Toole TE. Modulation of cell adhesion by changes in alpha L beta 2 (LFA-1, CD11a/CD18) cytoplasmic domain/cytoskeleton interaction. J Exp Med 1995;181:315-326.
17. Pardi R, Inverardi L, Rugarli C, Bender JR. Antigen-receptor complex stimulation triggers protein kinase C-dependent CD11a/CD18-cytoskeleton association in T lymphocytes. J Cell Biol 1992;116:1211-1220.
18. Evans SS, Schleider DM, Bowman LA, Francis ML, Kansas GS, Black JD. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J Immunol 1999;162:3615-3624.
19. Nebe B, Bohn W, Pommerenke H, Rychly J. Flow cytometric detection of the association between: Cell surface receptors and the cytoskeleton. Cytometry 1997;28:66-73.
20. Nebe B, Bohn W, Sanftleben H, Rychly J. Induction of a physical linkage between integrins and the cytoskeleton depends on intracellular calcium in an epithelial cell line. Exp Cell Res 1996;229:100-110.
21. Calcium channel blockers in heart failure. Cardiology 1998;89:38-46.
22. Nayler WG, ed. Second Generation of Calcium Antagonists. Berlin: Springer-Verlag, 1991.
23. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA. Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 2000;295:302-308.
24. Kobrin I, Bieska G, Charlon V, Lindberg E, Pordy R. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist. Cardiology 1998;89:23-32.
25. Clozel JP, Ertel EA, Ertel SI. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens Suppl 1997;15:S17-S25.
26. Leuranguer V, Mangoni ME, Nargeot J, Richard S. Inhibition of T-type and L-type calcium channels by mibefradil: Physiologic and pharmacologic bases of cardiovascular effects. J Cardiovasc Pharmacol 2001;37:649-661.
27. Noll G, Luscher TF. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade. Cardiology 1998;89:10-15.
28. 2+ channels by Ro 40-5967. Circ Res 1994;75:144-148.
29. Hoffman S, Gopalakrishna R, Gundimeda U, et al. Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells. Exp Eye Res 1998;67:45-52.
30. Matsumori A, Ono K, Nishio R, Nose Y, Sasayama S. Amlodipine inhibits the production of cytokines induced by ouabain. Cytokine 2000;12:294-297.
31. 2+ release in cultured rat cardiac fibroblasts and human platelets. Naunyn Schmiedebergs Arch Pharmacol 1995;353:94-101.
32. Chouabe C, Drici MD, Romey G, Barhanin J. Effects of calcium channel blockers on cloned cardiac K+ channels IKr and IKs. Therapie 2000;55:195-202.
33. Petrov V, Lijnen P. Inhibition of proliferation of human peripheral blood mononuclear cells by calcium antagonists. Role of interleukin-2. Methods Find Exp Clin Pharmacol 2000;22:19-23.
34. Nilius B, Prenen J, Kamouchi M, Viana F, Voets T, Droogmans G. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl-channels in macrovascular endothelial cells. Br J Pharmacol 1997;121:547-555.
35. 2+ antagonist, Ro 40-5967. J Vasc Res 1996;33:71-77.
36. 2+-dependent protease, calpain. J Cell Biol 1998;140:699-707.
37. Vandenberghe PA, Ceuppens JL. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods 1990;127:197-205.
38. Nebe B, Rychly J, Knopp A, Bohn W. Mechanical induction of beta 1-integrin-mediated calcium signaling in a hepatocyte cell line. Exp Cell Res 1995;218:479-484.
39. Lijnen P, Fagard R, Petrov V. Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells. J Cardiovasc Pharmacol 1999;33:479-484
40. Loike JD, Cao L, Budhu S, et al. Differential regulation of beta1 integrins by chemoattractants regulates neutrophil migration through fibrin. J Cell Biol 1999;144:1047-1056.
41. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: Tethering and signaling molecules. Immunol Today 1992;13:93-100.
42. Hogg N, Landis RC. Adhesion molecules in cell interactions. Curr Opin Immunol 1993;5:383-390.
43. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-314.
44. Blaheta RA, Hailer NP, Brude N, et al. Novel mode of action of the calcium antagonist mibefradil (Ro 40-5967): Potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium. Immunology 1998;94:213-220.
45. Lub M, van Kooyk Y, van Vliet SJ, Figdor CG. Dual role of the actin cytoskeleton in regulating cell adhesion mediated by the integrin lymphocyte function-associated molecule-1. Mol Biol Cell 1997;8:341-351.
46. Sampath R, Gallagher P.J, Pavalko FM. Cytoskeletal interactions with the leukocyte integrin beta2 cytoplasmic tail. Activation-dependent regulation of associations with talin and alpha-actinin. J Biol Chem 1998;273:33588-33594.
47. Kucik DF, Dustin ML, Miller JM, Brown EJ. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 1996;97:2139-2144.
48. Gimond C, de Melker A, Aumailley M, Sonnenberg A. The cytoplasmic domain of alpha 6A integrin subunit is an in vitro substrate for protein kinase C. Exp Cell Res 1995;216:232-235.
49. Lewis JM, Cheresh DA, Schwartz MA. Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J Cell Biol 1996;134:1323-1332.
50. Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Annu Rev Immunol 1995;13:623-653.
51. Lewis RS. Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol 2001;19:497-521.
52. Hahn M, Tkachuk VA, Bochkov VN, Cheglakov IB, Clozel JP. Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): Effects on intracellular calcium and platelet aggregation. Cardiovasc Drugs Ther 1995;9:815-821.
53. Yue L, Peng JB, Hediger MA, Clapham DE. CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature 2001;410:705-709.
54. Putney JW Jr, Broad LM, Braun FJ, Lievremont JP, Bird GS. Mechanisms of capacitative calcium entry. J Cell Sci 2001;114:2223-2229.
55. Nick JA, Avdi NJ, Young SK, et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest 1997;99:975-986.
56. Pellegatta F, Radaelli A, Heltai S, Yah L, Chierchia SL, Folli F. Evidence for the involvement of phosphatidylinositol 3-kinase in fMLP-stimulated neutrophil adhesion to ICAM1-transfected cells. J Cardiovasc Pharmacol 2001;37:751-761.
57. Bilici D, Akpinar E, Gursan N, Dengliz GO, Bilici S, Alta S. Protective effect of t-type calcium channel blocker in histamine-induced paw inflammation in rat. Pharmacol Res 2001;44:527-531.